Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Journal of the Pediatric Infectious Diseases Society
|
October 10, 2017
Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship
Tamar F Barlam, Jake R Morgan, Warren A Kaplan, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
October 4, 2013
Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009
Kevin Outterson, John H Powers, Enrique Seoane-Vazquez, et al.
Plos Medicine
|
June 15, 2016
Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality
Kevin Outterson, Unni Gopinathan, Charles Clift, et al.
Journal of Pharmaceutical Policy and Practice
|
April 11, 2018
Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations
Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, et al.
Nature Reviews. Microbiology
|
November 21, 2019
Antibiotic development - economic, regulatory and societal challenges
Christine Årdal, Manica Balasegaram, Ramanan Laxminarayan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 31, 2020
Antibiotic Development Incentives That Reflect Societal Value of Antibiotics
Helen W Boucher, Thomas M File, Vance G Fowler, et al.
CA: a Cancer Journal for Clinicians
|
September 21, 2021
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward
Amila K Nanayakkara, Helen W Boucher, Vance G Fowler, et al.
The Lancet. Infectious Diseases
|
July 11, 2017
To the G20: incentivising antibacterial research and development
Christine Årdal, Enrico Baraldi, Francesco Ciabuschi, et al.
Nature Communications
|
May 19, 2021
The effect of generic market entry on antibiotic prescriptions in the United States
Cecilia Kållberg, Jemma Hudson, Hege Salvesen Blix, et al.
Bulletin of the World Health Organization
|
April 18, 2015
An international legal framework to address antimicrobial resistance
Steven J Hoffman, Kevin Outterson, John-Arne Røttingen, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Journal of the Pediatric Infectious Diseases Society
|
October 10, 2017
Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship
Tamar F Barlam, Jake R Morgan, Warren A Kaplan, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
October 4, 2013
Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009
Kevin Outterson, John H Powers, Enrique Seoane-Vazquez, et al.
Plos Medicine
|
June 15, 2016
Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality
Kevin Outterson, Unni Gopinathan, Charles Clift, et al.
Journal of Pharmaceutical Policy and Practice
|
April 11, 2018
Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations
Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, et al.
Nature Reviews. Microbiology
|
November 21, 2019
Antibiotic development - economic, regulatory and societal challenges
Christine Årdal, Manica Balasegaram, Ramanan Laxminarayan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 31, 2020
Antibiotic Development Incentives That Reflect Societal Value of Antibiotics
Helen W Boucher, Thomas M File, Vance G Fowler, et al.
CA: a Cancer Journal for Clinicians
|
September 21, 2021
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward
Amila K Nanayakkara, Helen W Boucher, Vance G Fowler, et al.
The Lancet. Infectious Diseases
|
July 11, 2017
To the G20: incentivising antibacterial research and development
Christine Årdal, Enrico Baraldi, Francesco Ciabuschi, et al.
Nature Communications
|
May 19, 2021
The effect of generic market entry on antibiotic prescriptions in the United States
Cecilia Kållberg, Jemma Hudson, Hege Salvesen Blix, et al.
Bulletin of the World Health Organization
|
April 18, 2015
An international legal framework to address antimicrobial resistance
Steven J Hoffman, Kevin Outterson, John-Arne Røttingen, et al.
Page
of 8